
The decision to terminate the partnership follows the recent release of results from Advancis' Amoxicillin PULSYS Phase III clinical trials.

The decision to terminate the partnership follows the recent release of results from Advancis' Amoxicillin PULSYS Phase III clinical trials.

Oxford BioMedica (LSE: OXB), the leading gene therapy company, announced today that the first stage of its Phase II trial in pancreatic cancer with MetXia, the Company's gene targeted prodrug activation product, has been successfully completed.

The Drug Information Association (DIA) today announced a record number of attendees to its 41st Annual Meeting, which took place from June 26-30, 2005 at the Washington Convention Center in Washington, D.C.

Relisys Medical Devices Ltd. announced starting of the International Multi Centre Registry of its new Drug-Eluting Stent.

Tools for Clinical Trials Professionals

Movement to Unify Physician Investigators into One Comprehensive Organization Progresses as ACRP and AAPP Form Official Affiliation

Corporate Compliance Software Helps Hospital Keep Track of Ever-Changing Rules and Regulations

Monitor For Hire will provide Outcome with access to more than 2,000 experienced monitors to support the company's project and data management flow for post-approval studies.

Co-founder of BioMedical Diagnostics, Daniel Pierron, invests alongside Sofimac and BNP Paribas Développement

Achieves 17% Revenue Growth and EPS of $0.05 Versus a Loss in the Prior Year

MOSS Institute Co., Ltd. announced that its electronic data capture (EDC) system CLASSY fully complies with the U.S. Food and Drug Administration’s (FDA) Part 11 of Title 21 of the Code of Federal Regulations

ClinPhone, the global leader in clinical technology solutions, has introduced its new data center following the successful growth of the business.

Gilead Sciences, Inc. (Nasdaq: GILD) has begun enrolling patients in its Phase III clinical program evaluating the oral antiviral drug tenofovir disoproxil fumarate (tenofovir DF) for the treatment of chronic hepatitis B.

Continuing ICTI’s leadership in Adaptive Clinical Trial Design and Implementation, ICTI’s Manager of Biostatistics, Eva Miller, Ph.D., has been invited to present at the upcoming meeting of the International Society for Analysis, its Applications, and Computation (ISAAC).

Provides Foundation for Comprehensive Drug Development; Marketing Agreement Offers Continuum of Services

Center of Laboratory Medicine, Hua Shan Hospital in Shanghai distinguished as only NGSP Level 1 laboratory in China linked to global clinical trial network

Antiviral drug discovery services and clinical trials support

images

Tools for Clinical Trials Professionals

A pictorial view from around the show floor

Datatrial, Ltd, an innovative provider of data management solutions for the clinical research industry, announced further expansion of its global operations with the opening of North American Headquarters in Raleigh, North Carolina.

Company adds key staff, augments infrastructure, launches new corporate logo, and plans to expand into new clinical research markets.

New Offering Signals First Fully Comprehensive eCTD Solution

Medidata 2

Market-leading eDiary provider first to market with cost-effective training solution

Partnership Designed to Expand ePRO Options Available in Clinical Research

LifeTree eClinicalTM, a member of the FFF Enterprises Inc. family of companies and a leading provider of clinical electronic data capture and analysis systems, today announced that the company has entered into a partnership with Novotech, a full service contract research organization (CRO) based in Australia.

Key Functionality Drives Data Precision in Patient-Reported Outcomes-Based Research

First Consulting Group (FCG), (NASDAQ: FCGI), an information technology (IT) consulting, integration and outsourcing leader in healthcare, has named Richard Skinner Vice President in its healthcare IT practice.